Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 657

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 657
---
’s historical equity, the derecognition of certain assets and liabilities in both TuHURA’s and Kineta’s historical balance sheets that pertained to the initial exclusivity payments as a result of the Closing, and the other cash and stock consideration components of the aggregate Merger Consideration in the Mergers which are reflected in the “Estimated Purchase Price Consideration for the Mergers” section earlier in this Note 4 of the notes to the unaudited pro forma condensed combined financial information.

<div align='center'>426</div>

#### NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATIONThe preliminary calculation of the estimated preliminary purchase price allocation for the Business Combination in the aggregate and the corresponding aggregate Merger Consideration in the Mergers is presented in the table below as if the Business Combination closed on September 30, 2024 (in thousands):Fair ValueCash Consideration$10,526Share Consideration20,000Contingent Consideration—Total consideration$30,526Assets acquired:Cash and cash equivalents1,949Restricted cash4Prepaid expenses and other current assets265In-processresearch and development272Goodwill34,844Total assets acquired$37,334Liabilities assumed:Accounts payable and accrued expenses6,063Notes payable, current portion629Total liabilities assumed6,692Estimated fair value of net assets acquired$30,526In connection with the Business Combination, the Company will recognize approximately $272 of identifiable intangible assets pertaining to theIn-processresearch and development indefinite-lived intangible asset being acquired in the acquisition of Kineta and $34,844 of goodwill, which represents the excess purchase price over fair value of identifiable net assets acquired, pursuant to the preliminary purchase price allocation. Goodwill will not be amortized, but instead will be tested for impairment at least annually or more frequently if certain indicators are present. In the event that the value of goodwill or other intangible assets have become impaired, an accounting charge for impairment during the period in which the determination is made may be recognized.IRelating to the Mergers, reflects the total estimated transaction costs of both TuHURA and Kineta already incurred and expected to be incurred to close the Mergers of $6,660,873; which is comprised of $4,905,552 of aggregate costs incurred by TuHURA and $1,755,321 incurred by Kineta.I1Kineta’s total estimated transaction costs of $1,755,321 include accounting advisory, legal,